NEW: Redenlab commence work with Royal Melbourne Hospital on mobile speech recording in multiple sclerosis

In collaboration with the Movement Disorders and Cognitive monitoring in MS group. Speech is being used as an outcome measure in a treatment trial for Tremor in MS.

Tags: , , ,

Related Post

Redenlab partners with BDCRC to support new NIH-funded Batten disease research

  • Posted on 19 November, 2025
    MEDIA RELEASE MELBOURNE, VIC - A newly formed research network focused on Batten disease, a rare and inherited brain disorder...
    Read more

    Phase 2a/b randomised placebo-controlled dose-escalation trial of triheptanoin for ataxia-telangiectasia

    • Posted on 25 July, 2025
      A new clinical trial has found early evidence that a metabolic therapy could improve outcomes for people with ataxia-telangiectasia (A-T),...
      Read more

      Rapid repetitive syllable sounds associate with episodic memory, executive function, and working memory in cognitively healthy and subjectively impaired older adults

      • Posted on 21 July, 2025
        Could a 10-second speech test repeating “pa,” “ta,” “ka” be the key to earlier detection of Alzheimer’s risk? Our new...
        Read more